Cited by 357Advanced Drug Delivery SystemsBarrier Structure and Function StudiesNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 217 of the 219 references it cites were found in a registry or an index.

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Open access

Bourganis, Vassilis, Kammona, Olga, Alexopoulos, Aleck, Kiparissides, Costas·2018·European Journal of Pharmaceutics and Biopharmaceutics

DOI 10.1016/j.ejpb.2018.05.009

Open this paper in CoChat — free account Open PDF

Abstract

Central nervous system (CNS) disorders (e.g., multiple sclerosis, Alzheimer's disease, etc.) represent a growing public health issue, primarily due to the increased life expectancy and the aging population. The treatment of such disorders is notably elaborate and requires the delivery of therapeutics to the brain in appropriate amounts to elicit a pharmacological response. However, despite the major advances both in neuroscience and drug delivery research, the administration of drugs to the CNS still remains elusive. It is commonly accepted that effectiveness-related issues arise due to the inability of parenterally administered macromolecules to cross the Blood-Brain Barrier (BBB) in order to access the CNS, thus impeding their successful delivery to brain tissues. As a result, the direct Nose-to-Brain delivery has emerged as a powerful strategy to circumvent the BBB and deliver drugs to the brain. The present review article attempts to highlight the different experimental and computational approaches pursued so far to attain and enhance the direct delivery of therapeutic agents to the brain and shed some light on the underlying mechanisms involved in the pathogenesis and treatment of neurological disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ejpb.2018.05.009

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 3,037
Macromolecular Crowding and Confinement: Biochemical, Biophysical, and Potential Physiological Consequences
Zhou, H., Rivas, G., & Minton, A. P. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125817 · Cited by 2,160
Nanoemulsions versus microemulsions: terminology, differences, and similarities
McClements, D. J. (2011) · Soft Matter · doi:10.1039/c2sm06903b · Cited by 1,786
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494
Barrier properties of mucus
Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.
Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,293
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,256

Flagged first, then by citations

Show all 219 references

2 of the 219 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

M. Dahlin, Nasal administration of compounds active in the Central Nervous System - Exploring the olfactory pathway, Uppsala University, Ph.D Dissertation, (2000).
V. Dhamankar, Cytochrome P450-mediated drug metabolizing activity in the nasal mucosa, The University of Iowa, Ph.D Dissertation, 2013.
Pardeshi, 2015, Novel nasal devices for the efficient drug delivery: A systemic review, Indian J. Nov. Drug Deliv., 7, 1
A. Mistry, The development and application of biological models for evaluation of direct nose-to-brain drug delivery systems. Ph.D Dissertation, University of Nottingham, (2009).
K. Inthavong, K. Zhang, J. Tu, Modelling submicron and micron particle deposition in a human nasal cavity, Seventh International Conference on CFD in the Minerals and Process Industries, CSIRO, Melbourne, Australia, 2009.

Sorted by citations

Items 201–300 of 357

Signaling pathways driving multiple sclerosis: From mechanisms to natural‑product interventions
El‐Dessouki, A. M., Shalaby, H. N., Khalaf, S. S., Abd‐Elmawla, M. A., Ghaiad, H. R., Mageed, S. S. A., El‐Shiekh, R. A., Ahmed, S., & Khalifa, H. O. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119543 · Cited by 10
Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity
Inoue, D., Yamashita, A., & To, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112350 · Cited by 10
Biomimetic Cell Membrane Vehicles: Navigating the BloodBrain Barrier for Enhanced CNS Drug Delivery
Alalwani, A. K., Ahad, S., & Dhaher, H. (2023) · Trends in Pharmaceutical Biotechnology · doi:10.57238/tpb.2023.144292.1004 · Cited by 10
Nanostructured Lipid Carriers of Donepezil Hydrochloride for the Treatment of Alzheimer’s Disease
Tekade, A. R., Susar, R., Kulkarni, G., Surwade, S., & Gaikwad, A. (2024) · Current Alzheimer Research · doi:10.2174/0115672050288659240229080535 · Cited by 10
Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting
Ibrahim, R. M., Teaima, M. H. M., El-Nabarawi, M. A., & Badawi, N. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105885 · Cited by 12
Exploring the Impact of Polysaccharide‐Based Nanoemulsions in Drug Delivery
Basu, B., Dutta, S., Rahaman, M., Dutta, S., Ansari, M. N., Prajapati, B. G., Dutta, A., & Ghosh, S. (2025) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35582 · Cited by 10
Development of Bozepinib-Loaded Nanocapsules for Nose-To-Brain Delivery: Preclinical Evaluation in Glioblastoma
Dias, A. D. F., Dallemole, D. R., Bruinsmann, F. A., Silva, L. F. L., Cruz‐López, O., Conejo‐García, A., Battastini, A. M. O., Rosa, J. M. C., Guterres, S. S., Pohlmann, A. R., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0164 · Cited by 10
Strategy to improve crude oil biodegradation in oligotrophic aquatic environments: W/O/W fertilized emulsions and hydrocarbonoclastic bacteria
Rodrigues, E. M., Teixeira, Á. V. N. D. C., Cesar, D. E., & Tótola, M. R. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00244-x · Cited by 10
A new exhalation-assisted aerosol delivery method for nasal administration
Guo, G. F., Zhang, L., Li, T., Li, C., Zhang, Y., Ren, H., Zheng, Q., Tong, Z., & Yu, A. (2023) · Powder Technology · doi:10.1016/j.powtec.2023.118708 · Cited by 9
Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme
Kumar, A., & Shukla, R. (2024) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2024.2396721 · Cited by 10
Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review
Botan, M. V. G., da Silva, J. B., & Bruschi, M. L. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02974-9 · Cited by 9
Cannabidiol-Loaded Nanostructured Lipid Carriers for Nose to Brain Delivery: An Effective Therapeutic Approach against Epilepsy
Wang, L., Li, Y., Liang, K., Liu, B., Luo, Q., Wang, W., Zhang, D., & Wang, Q. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00452 · Cited by 9
Nose-to-brain delivery of biologics and stem cells
Agrawal, M., Konwar, A. N., Alexander, A., & Borse, V. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00015-1 · Cited by 9
Surface modification of nanocarriers as a strategy to enhance the direct nose-to-brain drug delivery
Pardeshi, C. V., & Souto, E. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00006-0 · Cited by 9
Niosomes-Based Drug Delivery in Targeting the Brain Tumors Via Nasal Delivery
Gharbavi, M., Parvanian, S., Leilan, M. P., Tavangar, S., Parchianlou, M., & Sharafi, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_14 · Cited by 9
Nanovesicles for delivery of central nervous system drugs
Virmani, R., Virmani, T., & Pathak, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00004-3 · Cited by 9
Multifaceted implementation of nanotechnology in ameliorating therapeutic efficacy of soy phytoestrogens: Comprehensive review on the state of art
Othman, A. M., Shehata, E. M. M., & Elnaggar, Y. S. R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102269 · Cited by 9
Lipid nanocapsules: A Novel Strategy for Brain Targeting via Nasal Administration
Ibrahim, M. M., Basalious, E. B., Nabarawi, M. E., & Makhlouf, A. I. A. (2024) · Journal of Research in Pharmacy · doi:10.29228/jrp.717 · Cited by 7
Ceftriaxone-loaded albumin-based nanoparticles incorporated into in situ ionic sensitive nasal gels: Development, characterization, and nasal drug deposition studies
Mardikasari, S. A., Katona, G., Nodilo, L. N., Hafner, A., Kalogjera, L., Zadravec, D., Orosz, L. I., Burián, K., Balogh, G. T., & Csóka, I. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114743 · Cited by 8
Targeting the brain: various approaches and science involved
Bahadur, S., Naurange, T., Baghel, P., Sahu, M., & Yadu, K. (2020) · ScienceRise Pharmaceutical Science · doi:10.15587/2519-4852.2020.210824 · Cited by 8
Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery.
Maher, M. A., Kandeel, W. A., Hammam, O. A., Attia, Y. M., Mahmoud, S. S., & Salah, M. (2022) · PubMed · doi:10.14670/hh-18-421 · Cited by 9
Rational development of fingolimod nano-embedded microparticles as nose-to-brain neuroprotective therapy for ischemic stroke
Zhang, X., Su, G., Shao, Z., Chan, H. W., Li, S., Chow, S., Tsang, C. K., & Chow, S. F. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01721-8 · Cited by 8
Formulation considerations in enhancing olfactory mucosal deposition for nose-to-brain drug delivery
D’souza, A. A., Kahan, M. S., Yang, A., Padmakumar, S., Bleier, B. S., & Amiji, M. M. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02097-7 · Cited by 10
SOLID LIPID NANOPARTILCES: MODERN PROGRESS IN NOSE-TO-BRAIN TRANSDUCTION
SOWMYA, C., Kannan, S. P., & H., A. A. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i4.47897 · Cited by 7
Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease
Maisto, N., & Mango, D. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101057 · Cited by 7
Nasal drug delivery to olfactory region based on high-flow auxiliary gas method: A numerical simulation study
Guo, G. F., Zhang, L., Ren, H., Ding, Y., Zhang, Y., Tong, Z., & Yu, A. (2024) · Powder Technology · doi:10.1016/j.powtec.2024.120567 · Cited by 7
Intranasal administration of 99mTc-topiramate-loaded phospholipid magnesome potential route for enhanced brain delivery: Characterization, biodistribution, and pharmacokinetic behaviors
Sayyed, M. E., Motaleb, M. A., Ibrahim, I. T., El-Nabarawi, M. A., & Ahmed, M. A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103185 · Cited by 7
Nanocarrier-based intranasal drug delivery for enhanced neurological disorders treatment
Morim, E., Sarmento, B. F. C. C., & Pacheco, C. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-02019-z · Cited by 7
Nose-to-brain axis: mechanistic links between nasal microbiome dysbiosis, neuroinflammation, and brain disorders
Mathias, K., Petronilho, F. C., & Danielski, L. G. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.039 · Cited by 6
A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization
Li, L., Hao, J., Jiang, Y., Hao, P., Gao, Y., Chen, J., Zhang, G., Jin, N., Wang, M., & Li, C. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.005 · Cited by 6
Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination
Mwema, A., Gratpain, V., Učakar, B., Vanvarenberg, K., Perdaens, O., Pesch, V. V., Muccioli, G. G., & Rieux, A. D. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01535-8 · Cited by 6
Intranasal delivery of sulpiride nanostructured lipid carrier to central nervous system; in vitro characterization and in vivo study
Tawfeek, H. M., Mekkawy, A. I., Abdellatif, A. A., Aldosari, B. N., Mohammed-Saeid, W. A., & Elnaggar, M. G. (2024) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2024.2404034 · Cited by 9
Recent progress in nanoparticulate-based intranasal delivery for treating of different central nervous system diseases
Bseiso, E. A., Sheta, N. M., & Abdel-Haleem, K. M. (2024) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2024.2409807 · Cited by 6
Navigating into the Paradigm of Nose-to-brain Delivery of Nanotherapeutics and their Repurposing as Nanotheranostics for Neurodegenerative Diseases
Ali, A., Emad, N. A., Sultana, N., Waheed, A., Aqil, M., Sultana, Y., & Mujeeb, M. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273319597240927044906 · Cited by 6
Brain Targeting of Mirtazapine Via Transferosome Embedded Thermoresponsive Nasal Gel for Sustained Release and Augmenting Bioavailability
Shah, A. A., Mirza, R., & Javed, A. (2025) · BioNanoScience · doi:10.1007/s12668-025-01894-7 · Cited by 6
Bioadhesive Nanoparticles as Potent Drug Delivery Carriers
Rençber, S., Bülbül, E. Ö., Şenyiğit, Z. A., Okur, N. Ü., & Siafaka, P. I. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220613111635 · Cited by 6
Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route
Ainurofiq, A., Prasetya, A., Rahayu, B. G., Qadri, M. S. A., Kovusov, M., & Laksono, O. E. P. (2023) · Farmacja Polska · doi:10.32383/farmpol/163334 · Cited by 6
Intranasal delivery of drug-loaded polymeric nanomicelles for brain targeting: a comprehensive review
Alam, S., Hafeez, A., Ansari, J. A., Kaushal, V., & Kushwaha, S. P. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06367-2 · Cited by 5
Progress in nasal drug delivery research based on biomaterials
Qiu, H., Duan, X., Su, Y., Zeng, S., Zheng, D., & Liao, W. (2025) · APL Materials · doi:10.1063/5.0296863 · Cited by 5
Liposomes - Recent Advances, New Perspectives and Applications
Tyagi, R. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102167 · Cited by 5
Intra-nasal administration of sperm head turns neutrophil into reparative mode after PGE1- and/or Ang II receptor-mediated phagocytosis followed by expression of sperm head’s coding RNA
Pakravan, N., Hassan, Z. M., & Abbasi, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107696 · Cited by 5
Noninvasive method for achieving the regeneration of damaged nerves via ultrasonic nasal drops
Zhu, N., Wang, F., Han, Z., Ling, S., Wong, D. W., Ye, S., Liu, M., Chen, Y., Shen, G., Ni, M., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.02.022 · Cited by 4
Intranasal Delivery of Lipid Nanoparticles: A Ground-breaking Approach for Brain Targeting
Jena, D., Srivastava, N., Yasir, M., & Dan, D. (2023) · Current Nanomaterials · doi:10.2174/2405461508666230804103023 · Cited by 4
Overcoming translational barriers in nose-to-brain drug delivery for clinical applications
Zhang, X., Chow, S., Chan, H. W., & Chow, S. F. (2026) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2026.104156 · Cited by 4
Developing a Solution for Nasal and Olfactory Transport of Nanomaterials
O’Connell, R. C., Dodd, T. M., Clingerman, S. M., Fluharty, K. L., Coyle, J. P., Stueckle, T. A., Porter, D. W., Bowers, L. N., Stefaniak, A. B., Knepp, A. K., et al. (2022) · Toxicologic Pathology · doi:10.1177/01926233221089209 · Cited by 4
Biomedical applications of nanocarriers in brain tumor targeting
Dighe, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00011-7 · Cited by 4
Nanocarriers-Assisted Nose-to-Brain Delivery of Levodopa: Current Progress and Prospects
Dangova, M., Ivanova, N. A., & Andonova, V. (2024) · Applied Sciences · doi:10.3390/app15010331 · Cited by 6
Intranasal Delivery of Leuprolide Acetate Chitosan Nanoparticles for Treatment of Alzheimer’s Disease
Pandya, T., & Dharamsi, A. T. (2023) · Drug Delivery Letters · doi:10.2174/2210303113666230120124831 · Cited by 4
Targeted Polymeric Nanoparticles as a Strategy for the Treatment of Glioblastoma: A Review
de Paula, G. A., de Paula, M. C., Dutra, J. A. P., Carvalho, S. G., Filippo, L. D. D., Villanova, J. C. O., & Chorilli, M. (2023) · Current Drug Delivery · doi:10.2174/0115672018257713231107060630 · Cited by 4
A dynamic study of VEGF-A siDOX-EVs trafficking through the in-vitro insert co-culture blood-brain barrier model by digital holographic microscopy
Shamshiripour, P., Rahnama, M., Nikoobakht, M., Hajiahmadi, F., Moradi, A., & Ahmadvand, D. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1292083 · Cited by 4
A pharmaco–technical investigation of oxaprozin and gaultheria oil nanoemulgel: a combination therapy
Talha, Ali, A., Mohapatra, S., Siddiqui, A., Farooq, U., Shamim, A., Jain, P., Aslam, M., Ansari, R., Mirza, M. A., et al. (2024) · RSC Pharmaceutics · doi:10.1039/d4pm00112e · Cited by 4
Ultrasound blood–brain barrier opening: A new era of treatment for Alzheimer's disease?
Wang, C., & Ren, J. (2024) · Aging Medicine · doi:10.1002/agm2.12371 · Cited by 3
Safe-by-Design Strategies for Intranasal Drug Delivery Systems: Machine and Deep Learning Solutions to Differentiate Epithelial Tissues via Attenuated Total Reflection Fourier Transform Infrared Spectroscopy
Topalian, R., Kavallaris, L., Rosenau, F., & Mavoungou, C. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00643 · Cited by 3
Revolutionizing high altitude cerebral edema management: nanotechnology-enabled diagnostics and targeted drug delivery
Chen, Y., Pei, J., Mou, J., Fan, J., Fan, L., Zhang, Y., Guo, X. W., Fan, Y., & Sun, H. (2025) · Smart Materials in Medicine · doi:10.1016/j.smaim.2025.06.002 · Cited by 3
Intranasal administration of thermoresponsive pterostilbene loaded nanoemulgel confers neuroprotection in a rat model of ischemic stroke
Dutta, B. J., Patil, V., Gaikwad, V. L., & Singh, S. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2574384 · Cited by 3
Nose-to-brain delivery of dopamine to the striatum of rats using neurotransmitter-loaded solid lipid nanoparticles: an in vivo study by brain microdialysis
Dazzi, L., Talani, G., Trapani, G., Capasso, L., Carbone, A., Gioia, S. D., Conese, M., Trapani, A., & Sanna, E. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110830 · Cited by 3
Brain Targeted Drug Delivery System of Carmustine: Design, Development, Characterization, in vitro, ex vivo Evaluation and in vivo Pharmacokinetic Study
Mali, A., & Bhanwase, A. S. (2024) · Acta chimica slovenica · doi:10.17344/acsi.2023.8461 · Cited by 3
Characterization of nasal spray aerosol fields using the extended interferometric particle imaging technique
Song, T., Lü, Q., Liu, H., & Tian, Q. (2024) · Measurement · doi:10.1016/j.measurement.2024.114733 · Cited by 3
Applications of direct nose-to-brain drug delivery in biomedicine, biotechnology, tissue engineering, and immunology
Patil, S. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00012-6 · Cited by 3
Nose to brain delivery of drugs for CNS diseases
Ali, Z. H., & Alkotaji, M. M. (2021) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2021.168804 · Cited by 3
Hyaluronate spreading validates mucin-agarose analogs as test systems to replace porcine nasal mucosa explants: An experimental and theoretical investigation
Spindler, L. M., Serpetsi, S. K., Flamm, J., Feuerhake, A., Böhler, L., Pravda, M., Borchers, K., Tovar, G. E. M., Schindowski, K., & Gruber‐Traub, C. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112689 · Cited by 3
Systematic Approach in the Development of Chitosan Functionalized Iloperidone Nanoemulsions for Transnasal Delivery, In Vitro and In Vivo Studies
Sawant, N. D., Tatke, P. A., & Desai, N. D. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02964-x · Cited by 3
Development and evaluation of niosome-based intranasal naloxone for enhanced drug delivery in opioid overdose treatment
Hnin, H. M., Tun, T., Nalinratana, N., & Jansook, P. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107277 · Cited by 3
Luteolin-loaded nanocomposites target microglia for sepsis-associated encephalopathy therapy via intranasal delivery
Guo, W., Liu, T., Peng, X., Zhang, J., Chen, Z., Xia, C., Yang, C., Xie, S., & Lü, T. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115433 · Cited by 2
Approaches for the delivery of anti-parkinsonian therapeutic agents via the intranasal route
Banyyounes, J., & Obeid, M. A. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00258-5 · Cited by 2
Nose-to-brain delivery of riluzole-loaded nanoemulsion in a controlled cortical impact-induced traumatic brain injury: Insights from In vitro, Ex vivo, and In vivo studies
Amulya, E., Kumari, D., Kumar, R., Vambhurkar, G. B., Dandekar, M. P., & Srivastava, S. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115955 · Cited by 2
Noninvasive Delivery of Biologicals to the Brain
Jordan, S., Zielinski, M. A., Kortylewski, M., Kuhn, T. P., & Bystritsky, A. (2022) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20210028 · Cited by 2
Nanostructured lipid carriers as an alternative carrier with high drug loading for targeting to brain tumors
Jitta, S. R., & Kumar, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00015-4 · Cited by 2
Essential considerations towards development of effective nasal antibiotic formulation: features, strategies, and future directions
Mardikasari, S. A., Katona, G., Sipos, B., & Csóka, I. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2341184 · Cited by 2
Targeted Nano-based Drug Delivery in Alzheimer's Disease and Dementia
Mal, P., Rath, S. K., & Halder, T. (2024) · Smart nanomaterials technology · doi:10.1007/978-981-97-0308-1_12 · Cited by 2
Transmucosal Drug Delivery: Main Physiological Features and Modern Approaches
Vanukuru, S., Al-Obaidi, H., & Khutoryanskiy, V. V. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_10 · Cited by 2
Targeted Brain Delivery of Therapeutics
Malaiya, A., Kewat, R., Paliwal, S. R., & Paliwal, R. (2024) · Springer eBooks · doi:10.1007/978-981-97-4970-6_13 · Cited by 2
Preparation and Optimization of Leuprolide Acetate Nanoparticles Using Response Surface Methodology: In Vitro and Ex Vivo Evaluation
Pandya, T., & Dharamsi, A. T. (2022) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.051 · Cited by 2
Vía intranasal: una alternativa para la administración de fármacos de acción central en equinos
Velloso, M. I., Ferreira, V., Vita, M., & Landoni, M. F. (2019) · Analecta Veterinaria · doi:10.24215/15142590e033 · Cited by 3
Clinical Applications of Pharmacokinetic and Pharmacodynamic Studies of Targeted Novel Drug Delivery Systems
Gharat, S., Momin, M. M., & Khan, T. A. (2024) · Springer eBooks · doi:10.1007/978-981-99-7858-8_5 · Cited by 1
Ex-vivo Imaging of Glial Energy Metabolism in the Neonatal Mouse Brain during Convulsive Seizures with Intranasal Radiotracer Administration
Hosoi, R., Tada, K., Hayakawa, T., & Haga, Y. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-025-02000-9 · Cited by 1
NGF-based cholinergic therapies in Alzheimer disease
Mitra, S., Gera, R., & Eriksdotter, M. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00007-x · Cited by 1
Cell-Penetrating Peptide-Decorated Nanovectors for Nose-to-Brain Delivery: A New Treatment Option for CNS Diseases
Sonvico, F., Bazzo, G. C., & Stulzer, H. K. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_9
Indoor ultrafine particles entering human respiratory regions: defining an index for maximum deposition dose probability in a university classroom case study
Pelliccioni, A., & Gherardi, M. (2025) · Atmospheric Pollution Research · doi:10.1016/j.apr.2025.102599 · Cited by 1
Screen-printed Electrodes for Detection of Neurotransmitters
Sharan, R., Prabhakaran, S., & Mohan, R. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837675593-00126 · Cited by 1
A Comprehensive Review of Nanoemulsion Via the Nose To the Brain in the Management of Parkinson’s Disease
Mahajan, H. S., Sarode, R. J., Deshmane, S. V., Girnar, G., & Khedekar, S. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10170-w · Cited by 1
Intranasal delivery of lipid-based nanoparticles for the treatment of neurodegenerative diseases: advances, challenges and future perspectives
Piera, X. M. I., Campo-Montoya, R. D., Cuadrado‐Tejedor, M., García‐Osta, A., Garbayo, E., & Blanco‐Prieto, M. J. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2587903 · Cited by 2
Quality by design of ultra deformable nanovesicles loaded with flunarizine for brain targeting utilizing risk assessment and multivariate analytical methods
Haiss, M. A., & Alhammid, S. N. A. (2025) · OpenNano · doi:10.1016/j.onano.2025.100265 · Cited by 1
Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases
Kalita, R., Sarma, A., Baruah, H., Zaman, A., & Goswami, D. (2026) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.70021 · Cited by 3
Carbon dots in nasal delivery: Emerging strategies for enhanced therapeutic efficacy
Kaid, N., Çamlık, G., & Özsoy, Y. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108028 · Cited by 1
Advances in Nose-to-Brain Delivery Systems for Effective Alzheimer's Disease Management
sahu, A., -, K., Patle, K., Jain, P., & ., A. (2026) · Current Alzheimer Research · doi:10.2174/0115672050395356251106100427 · Cited by 1
Nanomedicines for neurodegenerative ageing: nasal delivery innovations for Alzheimer’s and Parkinson’s disease
Upadhyay, R., Jain, A., Trivedi, K., & Desavathu, M. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2659210 · Cited by 1
Physicochemical, mechanical and rheological properties of poloxamer 407–hydroxypropyl methylcellulose based systems designed for nose-to-brain delivery of Trichilia catigua
Botan, M. V. G., de Mello, J. C. P., Rodrigues, F., & Bruschi, M. L. (2026) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2026.140719 · Cited by 1
Nanomedicine strategies for overcoming the blood–brain barrier in central nervous system drug delivery: mechanisms, advances, and challenges
Singh, M. P., Chettupalli, A. K., Bukke, S. P. N., Mugaiahgari, B. K. M., Uppu, P., Pathak, P., & Narapureddy, B. R. (2026) · BioMedical Engineering OnLine · doi:10.1186/s12938-026-01582-x · Cited by 1
Nanostructured Lipid Carriers for Synergistic Nose-to-Brain Delivery of Ropinirole Hydrochloride with Anise Oil for Parkinson’s Disease: Formulation and Preclinical Assessment
Ratnaparkhi, M. P., Jadhav, P. D., Kakad, A., Khiste, R. H., & Dalvi, S. D. (2026) · BioNanoScience · doi:10.1007/s12668-026-02677-4 · Cited by 1
Current Clinical Evidence on Nose-to-Brain Drug Delivery
Silva, A. C. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104765 · Cited by 1
Experimental models for evaluation of direct nose-to-brain drug delivery
Agnihotri, V. V., Gorle, A. P., Pardeshi, C. V., & Surana, S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00021-7 · Cited by 1
Development of an MRI-Compatible Nasal Drug Delivery Method for Probing Nicotine Addiction Dynamics
Mujica-Parodi, L. R., Kumar, R., Wenke, M. R., Amgalan, A., Lithen, A., Govindarajan, S. T., Makaryus, R., Benveniste, H., & Strey, H. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122069 · Cited by 1
Perspective Chapter: Nose-to-Brain Drug Delivery through Liposomes - Recent Applications
Hafeez, A., & Usmani, S. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106374 · Cited by 1
An Overview on Nanocarriers for Nasal Delivery
Dahiya, S., & Dahiya, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_9 · Cited by 2
Tracing the nose-to-brain nanoparticulate drug delivery using bio/chemoinformatics tools
Hathout, R. M., & Metwally, A. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89925-3.00009-5 · Cited by 1
Impact of phytomedicines and their novel delivery systems as an alternative for the treatment of neurodegenerative disorders
Nakhate, K. T., Mangrulkar, S. V., Badwaik, H. R., Choudhary, R., Baghel, M., Goyal, S. N., & Ajazuddin, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99125-4.00011-1 · Cited by 1
Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A Novel Approach to Diagnosis and Treatment
Khan, J., & Yadav, S. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385265554230919070402 · Cited by 1
Brain tumours: Non-invasive techniques to treat invasive pathologies
Barbotin, M., Thoreau, V., & Page, G. (2023) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2023.10.004 · Cited by 1
Liposomes for drug delivery to the brain
Agrawal, M., Singh, S., & Alexander, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15491-1.00006-7 · Cited by 1

Authors: Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C.
Affiliations: Aristotle University of Thessaloniki (GR)
Centre for Research and Technology Hellas (GR)
Corresponding author: Kiparissides, Costas
ORCID: Bourganis, Vassilis
Kammona, Olga
Alexopoulos, Aleck
Kiparissides, Costas
Venue: European Journal of Pharmaceutics and Biopharmaceutics
Publisher: Elsevier BV
Published: 2018-07
Volume: 128
Pages: 337-362
ISSN: 0939-6411 (ISSN-L)
DOI: 10.1016/j.ejpb.2018.05.009
OpenAlex: W2801808920
Cited by: 357
References: 219
Citations by year: 2026: 31 · 2025: 39 · 2024: 52 · 2023: 61 · 2022: 53 · 2021: 54 · 2020: 38 · 2019: 23 · 2018: 6
FWCI: 2.63
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: European Journal of Pharmaceutics and Biopharmaceutics (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: European Framework Programme for Research and Innovation Horizon 2020 (721098)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: nose-to-brain delivery, blood-brain barrier, brain drug delivery, central nervous system disorders, multiple sclerosis, Alzheimer's disease, intranasal drug delivery
MeSH terms: Administration, Intranasal, Animals, Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System Agents, Central Nervous System Diseases, Drug Carriers, Epithelium, Humans, Nasal Mucosa, Permeability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks